Naftifinklorid Jgl (Naftifine Hydrochloride)

Naftifine Hydrochloride is used to treat superficial fungal infections of the skin.

• Tinea corporis: clears ring‑shaped lesions and eliminates the causative dermatophytes.
• Tinea pedis: reduces scaling, itching and erythema associated with athlete’s foot.
• Tinea cruris: resolves jock‑itch symptoms and eradicates the fungal organisms.
• Tinea versicolor: normalises skin pigmentation by eliminating Malassezia species.
• Dermatophytosis: provides broad‑spectrum activity against a range of dermatophyte species.

• Naftifine Hydrochloride belongs to the allylamine class and selectively inhibits fungal squalene epoxidase, a key enzyme in ergosterol biosynthesis. Blocking this pathway leads to accumulation of toxic squalene and depletion of ergosterol, compromising fungal cell‑membrane integrity and resulting in fungal cell death.

Topical application of Naftifine Hydrochloride may be associated with the following adverse reactions.

Common Side Effects

• Application site burning: transient sensation of heat at the site of application.
• Itching: mild pruritus occurring during treatment.
• Redness: localized erythema of the treated area.
• Dryness or peeling: mild skin desiccation.

Serious or Rare Side Effects

• Severe allergic reaction: signs include swelling, hives, or difficulty breathing.
• Contact dermatitis: intense inflammation and blistering at the application site.
• Stevens‑Johnson syndrome: rare but serious mucocutaneous eruption requiring immediate medical attention.

Before using Naftifine Hydrochloride, consider the following precautions.

• Pregnancy: safety has not been established; consult a healthcare professional before use.
• Breastfeeding: limited data; discuss risks with a physician.
• Pediatric use: appropriate for children; follow prescriber guidance.
• Skin integrity: avoid application on broken or inflamed skin unless directed.
• Concomitant medications: inform the prescriber of any other topical products being used.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Naftifine Hydrochloride has a low potential for systemic drug interactions, but certain combinations may require attention.

Major Interactions (Avoid)

• None identified: no major systemic drug interactions have been reported for topical Naftifine.

Moderate Interactions (Monitor Closely)

• Other topical irritants: concurrent use with harsh soaps or chemicals may increase skin irritation.
• Corticosteroid‑containing creams: combined use may mask infection signs; monitor treatment response.
• Phototoxic agents: avoid excessive UV exposure on treated areas to reduce risk of photosensitivity.
• Alcohol‑based hand sanitizers: may affect absorption; advise spacing applications.